CONTACT: VIVUS, Inc. Dana B. Shinbaum (Corporate Development & Investor Relations) 650-934-5200 firstname.lastname@example.org The Trout Group Brian Korb (Managing Director) 646-378-2923 email@example.com
MOUNTAIN VIEW, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ:VVUS) today announced that it will provide an update and report financial results for the third quarter ended September 30, 2015 after the NASDAQ Market closes on Wednesday, November 4, 2015. The company will conduct a teleconference and an audio webcast at 4:30PM ET the same day. Date: November 4, 2015 Time: 4:30PM ET Listen via Internet: http://ir.vivus.com/ Schedule this webcast into MS-Outlook calendar (click open when prompted): http://apps.shareholder.com/PNWOutlook/t.aspx?m=70875&k=8DE79789 Toll-free: (877) 359-2916 International: (224) 357-2386 A webcast replay will be available on the VIVUS website for 30 days. VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health. For more information about the company, please visit www.vivus.com. Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ended December 31, 2014 as filed on February 25, 2015 and as amended by the Form 10-K/A filed on April 30, 2015, and periodic reports filed with the Securities and Exchange Commission.